![Alastair Garfield](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 685 628 $ au 31/05/2026
Alastair Garfield currently works at Rhythm Pharmaceuticals, Inc., as Chief Scientific Officer from 2024.
Dr. Garfield also formerly worked at Pfizer Inc., as Head-Lab, Rhythm Pharmaceuticals, Inc., as Head-Research & Development from 2017 to 2021, The University of Edinburgh, as Assistant Professor, and Rectify Pharmaceuticals LLC, as Senior VP & Head-Translational Research.
Dr. Garfield received his graduate degree and doctorate degree from the University of Bath.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/04/2026 | 7 763 ( 0,01 % ) | 685 628 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/07/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/05/2021 |
Rectify Pharmaceuticals LLC
 Rectify Pharmaceuticals LLC BiotechnologyHealth Technology Operates as a biotechnology company that develops positive functional modulators | Corporate Officer/Principal | - |
The University of Edinburgh
 The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| PFIZER INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Rhythm Pharmaceuticals, Inc.
 Rhythm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies peptide therapeutics for rare neuroendocrine diseases | Health Technology |
University of Bath
 University of Bath Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Edinburgh
The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rectify Pharmaceuticals LLC
Rectify Pharmaceuticals LLC BiotechnologyHealth Technology Operates as a biotechnology company that develops positive functional modulators | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
